L69 - Ott depression Flashcards
risk of recurrence in depression
1 episode: __%
2 episodes: ___%
3 episodes __ %
50-60
70
90
Acronym for DSM-5 diagnostic criteria
SIGE CAPS
Sleep
Interest decreased
Guilt/ worthlessness
Energy loss/ fatigue
Concentration difficulties
Appetite changes
Psychomotor
Suicidal ideation
Higher suicide risk
Longer duration of illness
Poor treatment response
A. w/ anxious distress
B. w/ melancholic features
C. w/ atypical features
A
Anhedonia
Psychomotor retardation/agitation -> worse in the morning, more likely in elderly
A. w/ anxious distress
B. w/ melancholic features
C. w/ atypical features
B
Reactive mood
Weight gain
Hypersomnia -> more likely in younger patient
A. w/ anxious distress
B. w/ melancholic features
C. w/ atypical features
C
3 self-administered rating scales
PHQ-9
QIDS-SR-16
MDQ
name the 3 phases of tx
acute
continuation
maintenance
the boxed warning for suicide in all antidepressants is for what age?
24 and below
what is the only ssri that does not require a taper
fluoxetine
what ssri has more GI upset than the others
sertraline
which ssri has dose dependent QTc prolongation
Citalopram
2C19 and 3A4 substrate ssri
citalopram
2D6 and 3A4 inhibitor ssri
fluoxetine
1A2 and 2C9 ssri
fluvoxamine
avoid in pregnancy
paroxetine
paroxetine CYPs
2D6 and 2B6
3 key adverse effects across all SSRIs
increased bleeding
hyponatremia
sexual dysfxn
specific paroxetine adverse effect (not related to pregnancy )
weight gain
specific adverse effect for fluoxetine
weight loss
Desvenlafaxine CYPS
none
SNRI with dose-limiting side effect of nausea
Desvenlafaxine
SNRI with FDA warning for hepatotoxicity
duloxetine
duloxetine CYP(s)
2D6
SNRI that you MUST adjust in renal impairment or strong 3A4 inhibitors
Levomilnacipran (fetzima)
SNRI that must be >150 mg/day to have NE effects
venlafaxine
which SNRI is a 2D6 inhibitor at higher doses
Venlafaxine
Venlafaxine CYP(s)
2D6 at high doses, and 3A4
2 main SNRI Adverse effects that were highlighted
BP elevation and Nausea